United States · FDA National Drug Code directory
LIDOCAINE HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1382_1e018450-f76a-22a2-e063-6394a90a061e
- Product NDC
- 51662-1382
- Form
- INJECTION
- Composition / generic term
- LIDOCAINE HCI
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191029
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 POUCH in 1 CASE (51662-1382-3) / 1 CARTON in 1 POUCH (51662-1382-2) / 1 SYRINGE in 1 CARTON (51662-1382-1) / 5 mL in 1 SYRINGE · 51662-1382-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →